We previously reported that human primary macrophage have approximately 100 times lower dNTP concentrations (20-40nM) than activated CD4+ T cells (2~5?M). The limited dNTP pools impose a strong restriction on HIV reverse transcription in macrophages. Several recent papers in Nature reported that Vpx, a co-packaged accessory protein of HIV-2 and SIVs, enhances viral infectivity in macrophages by degrading a myeloid cell specific, host viral restriction factor, SAMHD1, which suppresses HIV-1 replication in macrophages. Two more follow-up studies revealed that SAMHD1 is a dGTP-dependent dNTP hydrolase, which can hydrolyze and inactivate cellular dNTPs, suggesting that SAMHD1 restricts HIV-1 infection in nondividing macrophages by lowering cellular dNTP pools, which is logically consistent with our observation that the dNTP concentration in macrophages is extremely low. Indeed, our recently accepted report in Nature Immunology revealed that while SAMHD1 expression reduces cellular dNTP pools, Vpx efficiently elevates cellular dNTP concentrations by degrading SAMHD1 in macrophages, supporting that Vpx enhances HIV infectivity by promoting proviral DNA synthesis kinetics in myeloid cell types. We predict that cellular dNTP availability mechanistically influences three important events of HIV biology that occur during the early step of HIV life cycle: (1) Viral sensitivity to NRTIs: The EC50 for NRTI- mediated inhibition of virus replication in acutely infected macrophages is approximately 10-fold lower than that in T cells. We hypothesize that Vpx reduces viral sensitivity to NRTIs by increasing cellular dNTP pools while SAMHD1 expression enhances viral sensitivity to NRTIs by hydrolyzing cellular dNTPs, in macrophages, but not in activated CD4+ T cells. (2) Viral recombination frequency: HIV-1 RT pausing, which is induced by lowering dNTP concentration during DNA synthesis, initiates RNA template switching and recombination. Thus, we hypothesize that dNTP pool modulation induced by Vpx and SAMHD1 directly affects HIV-1 recombination frequency in macrophages, but not in T cells. (3) Incorporation of mutagenic noncanonical dUTP during proviral DNA synthesis: We have shown that there is a 60-fold disparity between levels of dTTP (low) and the noncanonical dUTP in macrophages, but not in T cells. We further showed that the cellular dUTP/TTP ratio determines the frequency of HIV-1 RT-mediated dUTP incorporation (which can be mutagenic). Thus we hypothesize that Vpx, which elevates cellular dNTP levels (including dTTP, but not dUTP), can minimize the incorporation of potentially mutagenic dUTP in macrophages. We will investigate the structural and enzymological features of the SAMHD1 active site involved in dNTP substrate specificity.
HIV-1 terminally differentiated/non-dividing macrophages serve as a long-living viral reservoir which contributes to persistent viral production and failureof HAART for HIV-1 eradication. A new anti-viral host factor, SAMHD1, is macrophage-specific, and thus, it is extremely important to understand the mechanistic interplays between this host factor and HIV-1 persistent infection in the long-living macrophage reservoirs because understanding this mechanism can lead to develop new and unique anti-HIV therapeutic strategies which are capable of eradicating specifically HIV infection to the long living viral reservoirs.
|Valle-Casuso, Jose Carlos; Allouch, Awatef; David, Annie et al. (2017) p21 Restricts HIV-1 in Monocyte-Derived Dendritic Cells through the Reduction of Deoxynucleoside Triphosphate Biosynthesis and Regulation of SAMHD1 Antiviral Activity. J Virol 91:|
|Hafez, A Y; Messinger, J E; McFadden, K et al. (2017) Limited nucleotide pools restrict Epstein-Barr virus-mediated B-cell immortalization. Oncogenesis 6:e349|
|Baldauf, Hanna-Mari; Stegmann, Lena; Schwarz, Sarah-Marie et al. (2017) Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells. Proc Natl Acad Sci U S A 114:2729-2734|
|White, Tommy E; Brandariz-Nuñez, Alberto; Martinez-Lopez, Alicia et al. (2017) A SAMHD1 mutation associated with Aicardi-Goutières syndrome uncouples the ability of SAMHD1 to restrict HIV-1 from its ability to downmodulate type I interferon in humans. Hum Mutat 38:658-668|
|Bloch, Nicolin; Gläsker, Sabine; Sitaram, Poojitha et al. (2017) A Highly Active Isoform of Lentivirus Restriction Factor SAMHD1 in Mouse. J Biol Chem 292:1068-1080|
|Hollenbaugh, Joseph A; Shelton, Jadd; Tao, Sijia et al. (2017) Substrates and Inhibitors of SAMHD1. PLoS One 12:e0169052|
|Mlcochova, Petra; Sutherland, Katherine A; Watters, Sarah A et al. (2017) A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages. EMBO J 36:604-616|
|Daddacha, Waaqo; Koyen, Allyson E; Bastien, Amanda J et al. (2017) SAMHD1 Promotes DNA End Resection to Facilitate DNA Repair by Homologous Recombination. Cell Rep 20:1921-1935|
|Rocha-Perugini, Vera; Suárez, Henar; Álvarez, Susana et al. (2017) CD81 association with SAMHD1 enhances HIV-1 reverse transcription by increasing dNTP levels. Nat Microbiol 2:1513-1522|
|Bhattacharya, Akash; Wang, Zhonghua; White, Tommy et al. (2016) Effects of T592 phosphomimetic mutations on tetramer stability and dNTPase activity of SAMHD1 can not explain the retroviral restriction defect. Sci Rep 6:31353|
Showing the most recent 10 out of 47 publications